相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer
Christopher H. Lieu et al.
CLINICAL CANCER RESEARCH (2019)
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T. Chang et al.
CANCER DISCOVERY (2018)
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Rona Yaeger et al.
CANCER CELL (2018)
The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects
Christian W. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
Recent developments in the treatment of metastatic colorectal cancer
Jonathan M. Loree et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer
Xian Hua Gao et al.
SCIENTIFIC REPORTS (2017)
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
D. Arnold et al.
ANNALS OF ONCOLOGY (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
Michael R. Burgess et al.
CELL (2017)
Young Age Increases Risk for Lymph Node Positivity in Early-Stage Rectal Cancer
Joshua E. Meyer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
Ondrej Fiala et al.
TUMOR BIOLOGY (2016)
Young Age Increases Risk for Lymph Node Positivity in Early-Stage Rectal Cancer
Joshua E. Meyer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis
Rao Watson et al.
HUMAN PATHOLOGY (2016)
RAS isoforms and mutations in cancer at a glance
G. Aaron Hobbs et al.
JOURNAL OF CELL SCIENCE (2016)
Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ
Srisathiyanarayanan Dharmaiah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The role of wild type RAS isoforms in cancer
Bingying Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Clinical and molecular features of young-onset colorectal cancer
Veroushka Ballester et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis et al.
CELL REPORTS (2016)
High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
Tanmay S. Chavan et al.
BIOPHYSICAL JOURNAL (2015)
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Fotios Loupakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010
Christina E. Bailey et al.
JAMA SURGERY (2015)
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
Fotios Loupakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
Yu Imamura et al.
MOLECULAR CANCER (2014)
Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study
Sylvain Kirzin et al.
PLOS ONE (2014)
Molecular Alterations and Biomarkers in Colorectal Cancer
William M. Grady et al.
TOXICOLOGIC PATHOLOGY (2014)
Early-onset colorectal cancer: A sporadic or inherited disease?
Vittoria Stigliano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
KRAS p.G13D Mutation and Codon 12 Mutations Are Not Created Equal in Predicting Clinical Outcomes of Cetuximab in Metastatic Colorectal Cancer A Systematic Review and Meta-Analysis
Chen Mao et al.
CANCER (2013)
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
Enric Domingo et al.
JOURNAL OF PATHOLOGY (2013)
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
Christophe Rosty et al.
MODERN PATHOLOGY (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Differences in Survival between Colon and Rectal Cancer from SEER Data
Yen-Chien Lee et al.
PLOS ONE (2013)
Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
Yu Imamura et al.
CLINICAL CANCER RESEARCH (2012)
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
Mai Yamauchi et al.
GUT (2012)
Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Amanda K. Arrington et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features
Daniel T. Chang et al.
MODERN PATHOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Germline KRAS Mutations Cause Aberrant Biochemical and Physical Properties Leading to Developmental Disorders
Lothar Gremer et al.
HUMAN MUTATION (2011)
Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
Gordon Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Increasing Incidence of Rectal Cancer in Patients Aged Younger Than 40 Years An Analysis of the Surveillance, Epidemiology, and End Results Database
Joshua E. Meyer et al.
CANCER (2010)
Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
Manickam Janakiraman et al.
CANCER RESEARCH (2010)
Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
Frank Benedix et al.
DISEASES OF THE COLON & RECTUM (2010)
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
M. Koopman et al.
BRITISH JOURNAL OF CANCER (2009)
Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B
Shin-ichi Asaka et al.
CARCINOGENESIS (2009)
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Bernard Levin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular classification and correlates in colorectal cancer
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12
Maria Virtudes Cespedes et al.
CARCINOGENESIS (2006)
Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age
S Kakar et al.
CANCER (2003)
分享论文
